Skip to main content

Sullivan James David's Form 4 filing

Bio Key International Inc (BKYI) · filed Nov 1, 2023

Accession no.
0001437749-23-029811
Filed
Nov 1, 2023, 5:04 PM ET
Trade date
Oct 30, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $49.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sullivan James DavidCIK 0001834436Officer (Chief Legal Officer), Other: SVP Strategy & Compliance

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 30, 2023Common StockPPurchaseAcquired+228,000$0.175+$39,900358,500Direct
Oct 30, 2023Common StockPPurchaseAcquired+57,100$0.175+$9,992.5415,600Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 30, 2023common stockPPurchaseAcquired+228,000–F2–246,750Direct
Oct 30, 2023common stockPPurchaseAcquired+57,100–F2–303,850Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Warrants were purchased as part of a unit with each unit consisting of one share of common stock and one warrant at a purchase price of $0.175 per unit.

Referenced by the price of 2 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)